McKesson Ventures, established in 2014, is the venture capital arm of McKesson Corporation, a leading healthcare services and information technology company. Based in San Francisco, California, McKesson Ventures invests in early and growth-stage healthcare technology companies, focusing on digital health and technology-enabled services that serve the needs of pharmaceutical companies, pharmacies, healthcare providers, and patients. The firm seeks minority investments, typically ranging from $20 million to $25 million, to support entrepreneurs creating efficient healthcare delivery systems for key stakeholders across the healthcare economy.
Lumata Health is a technology-driven healthcare startup dedicated to preventing blindness caused by chronic eye conditions. Founded in 2017 by Dr. Stephen R. Fransen, an experienced ophthalmologist and retina specialist, the company manages thousands of at-risk patients across the United States. Lumata Health employs a human-led care coordination and management platform that is generally free for patients. The firm collaborates with physicians, payers, and health systems to deliver comprehensive care management services, leveraging advanced technology and data science. It focuses on improving clinical outcomes, enhancing patient satisfaction, and increasing clinic staff efficiency through between-visit patient support and care coordination. Lumata Health addresses treatment adherence challenges associated with conditions such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye, acting as a remote extension of in-clinic staff to facilitate recovery and better health outcomes for patients.
Lynx
Series A in 2025
Lynx is a fintech healthcare company that focuses on integrating financial solutions with healthcare services. Its API-connected platform facilitates healthcare payments, banking, and e-commerce, allowing businesses to offer tailored health-fintech solutions. By bridging the gap between health and finances, Lynx aims to enhance affordability, drive health engagement, and improve financial security for consumers. The company's technology infrastructure empowers partners to provide a seamless consumer experience, ultimately helping healthcare professionals improve patient outcomes and reduce administrative inefficiencies.
PRISM Vision Group
Acquisition in 2025
PRISM Vision Group is a healthcare company that specializes in comprehensive support services to eye care organizations. It specializes in advanced surgical, injection, and medical approaches for patients with all types of retinal problems.
Bluenote Health
Venture Round in 2024
Bluenote Health operates as an AI platform for life sciences.
Core Ventures Group
Acquisition in 2024
Core Ventures Group, LLC, established in 2012 and headquartered in Palo Alto, California, is a venture capital firm specializing in early-stage investments. It focuses on direct investments, particularly in seed/startup and early-stage B2B companies within the advanced information technology sector. The firm aims to be among the first investors in its portfolio companies, providing support and working closely with founders to help them succeed.
HarmonyCares
Venture Round in 2024
HarmonyCares specializes in delivering comprehensive medical care directly to clients in their homes. The company focuses on individuals with multiple chronic conditions, cognitive challenges, and psychosocial issues, offering a range of services that include primary and specialty care programs, home health services, hospice and palliative care, as well as diagnostic services such as radiology and laboratory testing. By providing high-quality, integrated care in a comfortable setting, HarmonyCares aims to meet the diverse health needs of patients, particularly the elderly, while also supplying durable medical equipment to enhance their home care experience. Rebranded from U.S. Medical Management in 2022, HarmonyCares emphasizes a physician-driven approach to ensure optimal health outcomes for its clients.
Atropos Health
Series B in 2024
Atropos Health is a technology company based in Palo Alto, California, founded in 2019. It specializes in developing a digital prognostogram platform, known as the Atropos Evidence Platform, which transforms health data into actionable real-world evidence. By integrating electronic medical record (EMR) data, the platform generates digital evidence tailored to individual patient outcomes. This enables healthcare institutions, life science companies, and researchers to utilize previously siloed EMR data effectively. The platform aims to close evidence gaps in healthcare, enhance clinical outcomes through data-driven care, and accelerate research initiatives. Atropos Health serves caregivers, healthcare organizations, and risk-bearing entities, contributing to advancements in evidence-based healthcare.
Compile
Acquisition in 2024
Compile is a technology company focused on the life sciences and healthcare industries, providing data-driven insights through its Healthgraph platform. This platform utilizes a vast repository of medical claims, capturing approximately 70% of all claims from 2015 onwards, alongside a significant sample of prescription claims. By integrating this real-world data with various public sources, Compile offers pharmaceutical and medical device companies enhanced visibility into patient treatment pathways, healthcare professionals involved, and the relationships among healthcare organizations. The insights derived from Healthgraph assist clients in addressing critical questions throughout the entire commercial lifecycle, from pre-launch market research to post-launch strategies. Compile's solutions aim to organize and refine complex datasets into accessible and analytics-ready formats, facilitating informed decision-making in the healthcare sector.
Inbound Health
Series B in 2023
Inbound Health is a company that specializes in enabling health systems and health plans to implement hospital-at-home and skilled nursing-at-home programs. It has developed a health platform that utilizes AI-based technology to provide models for delivering hospital and skilled nursing facility-level care in patients' homes. This innovative approach allows for safe, predictive care that is both scalable and integrated, ensuring that patients receive real-time oversight and high-quality care in a familiar environment.
RxLightning
Series A in 2023
RxLightning is a digital platform focused on improving access to specialty medications by automating and streamlining the enrollment process. The company addresses the complexities associated with starting patients on specialty therapies across various fields, including addiction medicine, cardiology, endocrinology, and dermatology. By digitizing manual procedures, RxLightning reduces the burden of paperwork and enhances communication among healthcare providers, ultimately accelerating patients' speed to therapy. This innovative approach allows for a more efficient and effective management of specialty prescriptions, benefiting both healthcare professionals and patients alike.
Glide Health
Acquisition in 2023
Glide Health is a health technology company that specializes in providing intelligent financial solutions for healthcare organizations. Utilizing proprietary AI and machine learning, Glide Health enhances revenue and cash flow by integrating operations across various healthcare entities. The Glide Intelligence platform offers predictions and recommendations to optimize the revenue cycle, including patient registration, prior authorization, claim submission, denial management, and collections. It analyzes financial and clinical data in real time, generating actionable insights based on current trends. Additionally, Glide Mobile Health offers a centralized mobile solution that allows patients and healthcare professionals to access and manage patient information from various devices. This platform enables seamless collaboration, allowing patients to document their medical history and interact with healthcare providers while ensuring the privacy and security of their records. By improving compatibility among health information systems, Glide Health enhances the quality of care and facilitates better coordination in local and global healthcare settings. Overall, Glide Health aims to streamline healthcare operations and improve patient outcomes through innovative technology.
Glide Health
Acquisition in 2023
Glide Health is a health technology company that specializes in providing intelligent financial solutions for healthcare organizations. Utilizing proprietary AI and machine learning, Glide Health enhances revenue and cash flow by integrating operations across various healthcare entities. The Glide Intelligence platform offers predictions and recommendations to optimize the revenue cycle, including patient registration, prior authorization, claim submission, denial management, and collections. It analyzes financial and clinical data in real time, generating actionable insights based on current trends. Additionally, Glide Mobile Health offers a centralized mobile solution that allows patients and healthcare professionals to access and manage patient information from various devices. This platform enables seamless collaboration, allowing patients to document their medical history and interact with healthcare providers while ensuring the privacy and security of their records. By improving compatibility among health information systems, Glide Health enhances the quality of care and facilitates better coordination in local and global healthcare settings. Overall, Glide Health aims to streamline healthcare operations and improve patient outcomes through innovative technology.
Perceiv AI
Seed Round in 2022
Perceiv AI is a healthcare company focused on precision medicine, utilizing advanced artificial intelligence to enhance patient outcomes. The company specializes in identifying suitable subjects for clinical trials, helping pharmaceutical firms improve their chances of success by analyzing complex data related to heterogeneous diseases. Perceiv's platform integrates various types of longitudinal data, including imaging, genetic, phenotypic, and clinical variables, to characterize individuals more accurately. This approach enables healthcare organizations to target individuals at risk of disease progression, particularly in areas such as age-related conditions, including Alzheimer's disease and cardiovascular issues. Through its innovative AI-driven solutions, Perceiv aims to facilitate the development of effective therapies and improve the efficacy of clinical trials.
Rx Savings Solutions
Acquisition in 2022
Rx Savings Solutions is a healthcare technology company that focuses on reducing prescription drug costs for individuals and payers. Founded by a pharmacist, the company offers a software platform that analyzes medication claims data using proprietary algorithms to provide personalized recommendations. This enables over 9 million members to make informed decisions about their prescriptions. The platform enhances member engagement and features dedicated pharmacy experts who assist in navigating benefits, providers, and pharmacies. By promoting transparency and education, Rx Savings Solutions aims to help clients optimize their therapies while achieving substantial savings on prescription medications.
OncoHealth
Private Equity Round in 2022
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.
CancerIQ
Series B in 2022
CancerIQ is a precision health technology company that provides a platform designed to assist healthcare providers in identifying and managing patients at high risk for cancer. The platform features predictive analytics and screening tools to help clinicians detect at-risk patients early. It includes a comprehensive library of evidence-based guidelines and risk models, which aids providers in interpreting data and guiding patients toward appropriate genetic testing, screening, and treatment interventions. Additionally, CancerIQ offers a digital genetic test ordering system and patient management tools, enhancing clinician efficiency and improving patient outcomes by facilitating early cancer detection and adherence to evidence-based care strategies.
Koneksa
Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.
Reimagine Care
Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Established in 2020 and based in Nashville, Tennessee, the company seeks to improve the affordability, accessibility, and patient-centricity of cancer care. By collaborating with healthcare systems and independent oncology practices, Reimagine Care supports value-based oncology care delivery. Their approach involves providing the necessary personnel, processes, and a comprehensive technology platform that facilitates the effective and scalable delivery of high-quality cancer care at various locations, including patients' homes. This model aims to enable patients to receive treatment and supportive care in a more convenient and cost-effective manner.
Lightship
Series C in 2021
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.
IVX Health
Series F in 2021
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.
AllStripes
Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of treatments for rare diseases. The company has created a platform that produces regulatory-ready evidence to support rare disease research and drug development. This platform operates as a two-sided network where patients with rare diseases and advocacy groups contribute valuable information, while life science companies utilize this data to identify new drug candidates. Additionally, AllStripes offers a patient application that allows individuals to engage in treatment research online and leverage their own medical data, fostering a collaborative environment aimed at advancing medical research for rare conditions.
Evidation Health
Series E in 2021
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.
M2Gen
Private Equity Round in 2021
M2Gen is a health informatics solutions company established in 2006 at the Moffitt Cancer Center in Tampa, Florida. The company specializes in advancing precision medicine by integrating and analyzing clinical and molecular data. Its integrated platform helps identify patient susceptibility to diseases, predict drug responses, and match patients with optimal therapies for better treatment outcomes. M2Gen also offers a portfolio designed for biopharmaceutical companies to discover new targets and biomarkers, enhance clinical trial design and enrollment, and conduct post-market analysis. One of its key initiatives is the Total Cancer Care Protocol, which studies patients throughout their lifetime, and the ORIEN Avatar Research Program, which focuses on individuals with advanced disease and limited treatment options. M2Gen operates as a subsidiary of the H. Lee Moffitt Cancer Center & Research Institute.
Aspen RxHealth
Series B in 2021
Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists to patients based on various social and clinical criteria, such as language and medication regimens. This platform enables health plans and providers to link their patients with a community of pharmacists who can deliver clinical services tailored to individual needs. The services offered include comprehensive medication reviews and targeted medication interventions, all aimed at optimizing communication and improving patient care.
Clinical Ink
Venture Round in 2020
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.
Vineti
Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.
Augmedix
Private Equity Round in 2020
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.
Koneksa
Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.
Pharmapacks
Private Equity Round in 2020
Pharmapacks is an e-commerce company based in Islandia, New York, specializing in health and beauty products. Established in 2010 as a brick-and-mortar pharmacy, the company has evolved into a comprehensive online marketplace that offers a wide range of items, including multivitamins, nutritional supplements, personal care, and pet care products. Through its proprietary technology platform, Pharmapacks provides logistics, fulfillment, marketing, and sales solutions to brands, enabling them to reach consumers directly via its website and partner platforms such as Amazon, Walmart.com, and eBay. The company also serves as a launchpad for emerging brands, granting select lesser-known products access to its extensive e-commerce infrastructure and consumer base, thereby enhancing their visibility and sales potential.
Evidation Health
Series D in 2020
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.
OncoHealth
Series C in 2020
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.
Amwell
Series C in 2020
Amwell is a telehealth platform based in the United States that facilitates the digital delivery of healthcare services. Founded in 2006 and headquartered in Boston, the company connects providers, insurers, patients, and innovators to enhance access to affordable, high-quality care. Amwell offers a comprehensive platform designed to address a wide range of telehealth needs, including urgent, acute, and post-acute care, as well as chronic care management and healthy living. With extensive experience in the field, Amwell supports over 240 health systems, which encompass 2,000 hospitals, and collaborates with 55 health plan partners, reaching more than 150 million individuals through over 36,000 employers. The platform provides both on-demand and scheduled consultations, enabling diverse care models that range from primary and urgent care to specialized services such as telestroke and telepsychiatry.
Lightship
Series B in 2020
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.
Matternet
Series B in 2020
Matternet is a prominent developer of commercial drone delivery systems aimed at urban and suburban environments. The company offers the Matternet M2 drone along with its proprietary software platform, which allows for automated package exchange and efficient logistics operations. Matternet has established itself as a pioneer in the industry, being the first to gain authorization for commercial Beyond Visual Line of Sight (BVLOS) drone operations in Switzerland in 2017. In collaboration with logistics partners like UPS, Matternet launched drone delivery services in the U.S. in 2019, marking the beginning of revenue-generating drone delivery operations in the country. The Matternet M2 drone achieved significant regulatory milestones, becoming the first drone delivery system to be certified by the Federal Aviation Administration (FAA) in 2022. To date, Matternet's technology has facilitated over 20,000 commercial flights, demonstrating its capability in building and operating comprehensive drone logistics networks for transporting goods.
Augmedix
Series B in 2019
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.
IVX Health
Series C in 2019
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.
Echo
Acquisition in 2019
Echo, we believe health is about people, not pills. That’s why we’ve created a new kind of pharmacy. One that comes to you, not the other way around. We start with being brilliant at fulfilling prescriptions because getting people taking the right medicine is the first step in staying well. But there’s more we can do. It’s not just patients we support, its partners. Together with other like-minded pharmacies, GPs and prescribing services we deliver even more positive experiences. Ultimately, we want to help patients understand and do more for themselves, so together they can make the right decisions with their GPs. And when it comes time to improve our health, we all know more Technology should make the future of health care more human. So ours comes packed with care.
AllyAlign Health
Corporate Round in 2019
AllyAlign Health operates as a care management company dedicated to supporting patients with chronic and complex medical conditions. Founded in 2013 and based in Glen Allen, Virginia, the company offers an active care management platform that facilitates real-time, collaborative care across various boundaries. This platform connects patients with care teams, providers, and community-based services, ensuring access to essential health information, care plans, and benefits necessary for informed decision-making. Users can easily view, share, create, and update information according to their roles and responsibilities, with mobile and web-based options enhancing accessibility for patients and their families. A central, HIPAA-compliant database consolidates information from multiple sources, including electronic health records and lab tests, while semantic data modeling provides meaningful clinical insights.
Xealth
Series A in 2019
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.
Aetion
Series B in 2019
Aetion, Inc. is a healthcare analytics company that specializes in real-world evidence (RWE) and outcomes-based analytics solutions. Founded in 2012 and based in New York City, Aetion develops the Aetion Evidence Platform, which leverages everyday clinical and financial interactions within the healthcare system to generate critical insights about the effectiveness and value of medical treatments. This platform serves a diverse clientele, including life sciences companies, payers, providers, medical device manufacturers, and academic institutions, allowing them to analyze data from various sources such as claims, electronic health records, registries, and clinical trials. Aetion’s patented rapid-cycle analytics technology facilitates real-time collaboration among stakeholders, enabling them to make informed decisions and optimize patient care. The company has formed strategic partnerships with leading organizations, including McKesson, to enhance its offerings and expand its reach in the healthcare sector.
OncoHealth
Series B in 2018
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.
Pharmapacks
Series A in 2018
Pharmapacks is an e-commerce company based in Islandia, New York, specializing in health and beauty products. Established in 2010 as a brick-and-mortar pharmacy, the company has evolved into a comprehensive online marketplace that offers a wide range of items, including multivitamins, nutritional supplements, personal care, and pet care products. Through its proprietary technology platform, Pharmapacks provides logistics, fulfillment, marketing, and sales solutions to brands, enabling them to reach consumers directly via its website and partner platforms such as Amazon, Walmart.com, and eBay. The company also serves as a launchpad for emerging brands, granting select lesser-known products access to its extensive e-commerce infrastructure and consumer base, thereby enhancing their visibility and sales potential.
Propeller Health
Corporate Round in 2018
Propeller Health is a digital health platform focused on improving the management of chronic respiratory diseases such as asthma and COPD. The company provides a mobile application and sensors that attach to inhalers, enabling users to track their medication usage, triggers, and symptoms. This data is stored securely in a cloud-based infrastructure and facilitates personalized feedback and education for users. The platform also allows users to set medication reminders and alerts, as well as share their health data with physicians and family members. Propeller Health collaborates with various healthcare organizations and has received multiple awards for innovation in the field. Founded by David Van Sickle, Greg Tracy, and Mark Gehring, the company operates from Wisconsin, United States.
Medical Specialties Distributors
Acquisition in 2018
Medical Specialties Distributors, LLC is a full-service distributor of healthcare products primarily serving the home infusion, specialty pharmacy, and oncology markets. Founded in 1984 and based in Stoughton, Massachusetts, the company offers a wide range of products, including infusion pumps, IV supplies, pharmaceuticals, and various medical surgical products. They manufacture several specialized kits and devices, such as dressing change kits and IV administration sets, and provide additional services like biomedical equipment rental, maintenance, and repair. The company also supports clients with equipment management software and online training programs to enhance product utilization and operational efficiency. Medical Specialties Distributors operates a national network of distribution centers and an online ordering platform, with additional locations in Phoenix, Arizona; Bedford, Ohio; Gurnee, Illinois; and St. Louis, Missouri. As of June 2018, it operates as a subsidiary of McKesson Corporation.
Kyruus
Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Accolade
Series F in 2018
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
RxTPL
Acquisition in 2018
RxTPL is a pharmaceutical company that provides logistic management, graphics, marketing, IT capabilities, and order-to-cash services.
Well.ca
Acquisition in 2017
Well.ca Inc. is an online retailer specializing in health and wellness products, offering a wide range of items including baby and kids' products, beauty and skincare, personal care, diet and fitness, medicine, vitamins, and pet supplies. Established in 2008 and based in Guelph, Canada, the company serves customers throughout Canada and the continental United States. Well.ca aims to provide a straightforward and convenient shopping experience, featuring quick shipping and competitive pricing. As of December 2017, it operates as a subsidiary of McKesson Canada Corporation.
RxCrossroads
Acquisition in 2017
RxCrossroads Specialty Solutions specializes in pharmaceutical distribution services, focusing on enhancing patient access to therapies. The company offers a comprehensive suite of customized services designed to support both patients and healthcare providers. By streamlining access to medications, including specialty, generic, and bio-similar drugs, RxCrossroads aims to facilitate the commercial success of pharmaceuticals in the market. Their commitment to individualized support helps to differentiate their clients' products, ultimately improving patient outcomes and ensuring that therapies reach those in need.
IVX Health
Series B in 2017
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.
Truveris
Series D in 2017
Truveris, Inc. is a health information technology company based in New York that focuses on the management of pharmacy benefits and prescription drug costs. Founded in 2009, the company offers a comprehensive platform that includes solutions such as RxChoice, TruBid, and RxDash, which cater to various stakeholders in the prescription drug ecosystem, including pharmaceutical manufacturers, pharmacy benefit managers, and payers. Truveris leverages data-driven innovations to provide actionable insights that help clients navigate the complexities of pharmacy spending, ensure regulatory compliance, and validate claim payment accuracy. By offering tools for managing the entire pharmacy benefits lifecycle—from request for proposal to bill review—Truveris aims to enhance transparency and efficiency in the prescription drug market. The company's backing from multiple venture capital firms underscores its commitment to addressing rising costs and improving access to prescription medications.
intraFUSION
Acquisition in 2017
intraFUSION, Inc. is a national healthcare management company based in Houston, Texas, that specializes in the management of outpatient infusion centers located in physicians' offices. Founded in 1999, the company offers a comprehensive range of services, including financial analysis, space planning, staffing, billing, inventory control, and regulatory compliance, which are tailored to enhance the operational efficiency of infusion therapy practices. By serving as a single source manager, intraFUSION equips physicians with the necessary tools and best practices to deliver high-quality patient care while also creating new revenue streams for their medical practices. As a subsidiary of McKesson Specialty Health since 2017, intraFUSION continues to lead in outpatient infusion management, focusing on improving patient outcomes and supporting healthcare providers.
Carena
Series E in 2017
Carena is a Seattle-based company that specializes in virtual healthcare delivery, leveraging a combination of technology and innovative care methods. The organization provides a virtual care model and a configurable technology platform designed to enhance patient access to high-quality healthcare services. Their offerings include nurse lines, virtual house calls, wellness programs, and care management, allowing consumers to access on-demand primary care services at any time and from any location. Carena's commitment to improving the healthcare experience is evident in its 24/7 availability, which aims to create a new source of referrals for health systems while prioritizing patient care and convenience.
Unforgettable.org
Venture Round in 2017
Unforgettable is dedicated to enhancing the lives of individuals impacted by dementia through its extensive online marketplace, which features over 1,000 products designed to assist those with dementia in daily activities. Positioned as the leading destination for dementia-related products and services, Unforgettable not only facilitates the discovery and distribution of these resources but also provides valuable information, expert advice, and a platform for shared experiences. The company is supported by prominent social impact investors, including McKesson Ventures, and is recognized as a B Corp, reflecting its commitment to social good. In collaboration with Lloyds Pharmacy, Unforgettable has expanded its reach by introducing dementia products to physical retail locations, thereby increasing accessibility and raising awareness of the needs of individuals with dementia and their caregivers.
SHYFT Analytics
Series B in 2017
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
CoverMyMeds
Acquisition in 2017
CoverMyMeds, LLC, established in 2008 and headquartered in Highland Hills, Ohio, provides electronic prior authorization solutions to streamline the process of obtaining insurance approval for prescriptions. Its platform enables healthcare providers, pharmacies, and payers to complete prior authorization requests electronically, significantly reducing the time and effort involved in the process. CoverMyMeds offers a suite of integrated workflow tools that assist physicians and pharmacists in filling out necessary insurance forms for nearly all drug plans. The company generates revenue by partnering with pharmaceutical manufacturers to enhance patient access to branded medications. As of 2017, CoverMyMeds operates as a subsidiary of McKesson Corporation, further expanding its reach and capabilities in the healthcare industry.
Augmedix
Venture Round in 2016
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.
SHYFT Analytics
Series B in 2016
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.
HealthQx
Acquisition in 2016
HealthQX, founded in 2012 and based in King of Prussia, Pennsylvania, specializes in value-based payment analytic software solutions tailored for health plans and providers. The company's primary offering, ClarityQx, is a comprehensive analytics platform designed to facilitate the design, implementation, and ongoing performance monitoring of various payment models, including episodic, bundled, and accountable care arrangements. This platform provides users with drill-down dashboards that enhance provider engagement and streamline contract negotiation processes. By enabling quick access to critical payment analytics, HealthQX aims to improve consumer care and reduce medical costs within the healthcare industry.
RetraceHealth
Series A in 2016
RetraceHealth, Inc. operates an online platform that facilitates urgent and routine healthcare through video visits and in-person home visits. The platform focuses on providing services in preventive care, pediatric care, primary care, and management of chronic conditions such as high blood pressure and diabetes. Patients can access care via video visits in Minnesota and Wisconsin, while home visits are available in the Twin Cities metro area and other locations. Founded in 2013 and based in Minneapolis, Minnesota, RetraceHealth aims to deliver high-quality primary care that is both personal and affordable, offering services comparable to those found in traditional clinics but delivered directly to patients' homes. The company emphasizes accessible care options, connecting patients with trusted clinical professionals through technology-driven solutions.
Evariant
Series C in 2016
Evariant, Inc. is a healthcare technology company based in Farmington, Connecticut, founded in 2008. It provides a comprehensive platform designed to assist healthcare organizations in optimizing patient acquisition and retention while improving engagement with both patients and physicians. Evariant's solutions include tools for understanding patient demographics, managing marketing campaigns, and fostering two-way communication. The company offers a range of services, including analytics for tracking physician referral patterns, relationship management platforms for collaboration with healthcare providers, and recruitment tools for enhancing physician outreach. Additionally, Evariant provides digital media services, project management consulting, and a marketplace for healthcare analytics products. With a strong client base that includes over 1,000 hospitals nationwide, Evariant aims to drive growth and improve healthcare delivery by leveraging actionable intelligence and advanced data analytics.
Vantage Oncology
Acquisition in 2016
Vantage Oncology, Inc. specializes in providing comprehensive oncology care services, focusing on radiation oncology, medical oncology, and cancer treatment. The company addresses the increasing demand for advanced radiation therapies among cancer patients, hospitals, and physicians. Vantage offers a range of services, including radiation therapy and neurosurgical interventions for various cancer types, such as breast, lung, and prostate cancers. Additionally, Vantage promotes joint venture ownership opportunities, allowing physicians and hospitals to maintain control over their practices while benefiting from the company's extensive network and expertise in radiation oncology. This model not only enhances the capabilities of individual practices but also strengthens the overall quality of cancer care provided to patients.
Rexall
Acquisition in 2016
Rexall Health is an industry-leading healthcare management and technology firm that has been providing customized, value-added health benefit claims management and plan administrative services to Canadian corporations and other health benefit plan sponsors for over 30 years.
Biologics
Acquisition in 2016
Biologics, Inc. is an oncology management services company that specializes in optimizing cancer care for healthcare providers, payers, and biopharma organizations. Founded in 1994 and headquartered in Cary, North Carolina, the company offers a comprehensive range of services designed to improve clinical, financial, and emotional outcomes for patients. Its oncology pharmacy services include patient advocacy, drug therapy management, counseling, and prescription dispensing. Additionally, Biologics provides patient access services such as prior authorization management, financial assistance, and clinical trial enrollment. The company also delivers strategic market solutions that encompass drug commercialization planning and customized reporting. Furthermore, Biologics offers clinical research services, including investigational pharmacy solutions and post-marketing trials. By integrating fragmented healthcare services, Biologics aims to enhance efficiency and prioritize patient interests in the oncology care landscape.
PokitDok
Venture Round in 2016
PokitDok, Inc. is a cloud-based company that provides a comprehensive application programming interface (API) platform designed to facilitate various healthcare transactions. Founded in 2011 and headquartered in San Mateo, California, with an additional office in Charleston, South Carolina, PokitDok enables health systems, technology providers, and developers to enhance their applications by integrating services such as eligibility checks, claims submissions, appointment scheduling, payment processing, and patient identity management. The platform also offers insights on cash costs for health services and includes an e-commerce storefront for practitioners to market their services and allow consumers to pay for treatments upfront. By streamlining workflows and improving operational efficiency, PokitDok supports healthcare organizations in creating patient-centered experiences and modern commerce solutions across the healthcare value chain.
Komodo Health
Series A in 2016
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.
RetraceHealth
Seed Round in 2016
RetraceHealth, Inc. operates an online platform that facilitates urgent and routine healthcare through video visits and in-person home visits. The platform focuses on providing services in preventive care, pediatric care, primary care, and management of chronic conditions such as high blood pressure and diabetes. Patients can access care via video visits in Minnesota and Wisconsin, while home visits are available in the Twin Cities metro area and other locations. Founded in 2013 and based in Minneapolis, Minnesota, RetraceHealth aims to deliver high-quality primary care that is both personal and affordable, offering services comparable to those found in traditional clinics but delivered directly to patients' homes. The company emphasizes accessible care options, connecting patients with trusted clinical professionals through technology-driven solutions.
PokitDok
Series B in 2015
PokitDok, Inc. is a cloud-based company that provides a comprehensive application programming interface (API) platform designed to facilitate various healthcare transactions. Founded in 2011 and headquartered in San Mateo, California, with an additional office in Charleston, South Carolina, PokitDok enables health systems, technology providers, and developers to enhance their applications by integrating services such as eligibility checks, claims submissions, appointment scheduling, payment processing, and patient identity management. The platform also offers insights on cash costs for health services and includes an e-commerce storefront for practitioners to market their services and allow consumers to pay for treatments upfront. By streamlining workflows and improving operational efficiency, PokitDok supports healthcare organizations in creating patient-centered experiences and modern commerce solutions across the healthcare value chain.
ClearCare
Series C in 2015
ClearCare, Inc. is a technology company that provides a cloud-based platform designed for homecare service agencies, enabling them to manage their operations efficiently. Founded in 2010 and based in San Francisco, ClearCare offers a comprehensive suite of tools that includes scheduling, billing, payroll, customer relationship management, and caregiver training, among others. The platform addresses the needs of various stakeholders in the home care ecosystem, such as caregivers, agency staff, care recipients, and healthcare providers. By integrating these functionalities, ClearCare streamlines processes and enhances service delivery, particularly for seniors who are the primary users of home care services. As a subsidiary of WellSky Corporation since 2019, ClearCare continues to position itself at the forefront of the evolving home healthcare landscape.
Kyruus
Series C in 2015
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
UDG Healthcare
Acquisition in 2015
UDG Healthcare is a Dublin-based provider of healthcare advisory, communications, commercial, clinical, and packaging services. The company operates through two main divisions: Ashfield and Sharp. Ashfield delivers commercial and medical services, offering advisory, medical, marketing, communications, and patient engagement solutions throughout the lifecycle of a drug. Sharp focuses on packaging services, ensuring that healthcare products are efficiently packaged for market delivery. With a workforce of approximately 8,000 employees across 23 countries, UDG Healthcare specializes in innovative, outsourced solutions that help healthcare companies bring their products to market effectively and efficiently.
Accolade
Series E in 2015
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
PipelineRx
Venture Round in 2015
PipelineRx is a multi-state organization based in San Francisco, California, focused on telepharmacy and medication management. Founded in 2009 by Brian Roberts, the company develops a cloud-based platform that enhances pharmacy and patient care by utilizing telemedical technology. This platform reviews and verifies medication orders while documenting clinical interventions, allowing hospitals to improve operational efficiencies and clinical outcomes. PipelineRx also emphasizes leadership development and offers online community services tailored for hospital and retail pharmacies.
Carena
Series D in 2015
Carena is a Seattle-based company that specializes in virtual healthcare delivery, leveraging a combination of technology and innovative care methods. The organization provides a virtual care model and a configurable technology platform designed to enhance patient access to high-quality healthcare services. Their offerings include nurse lines, virtual house calls, wellness programs, and care management, allowing consumers to access on-demand primary care services at any time and from any location. Carena's commitment to improving the healthcare experience is evident in its 24/7 availability, which aims to create a new source of referrals for health systems while prioritizing patient care and convenience.
Celesio
Acquisition in 2013
Celesio AG is an international trading company that specializes in providing logistics and services in the pharmaceutical and healthcare sector across 16 countries worldwide. The company operates through two divisions: Patient and Consumer Solutions, and Pharmacy Solutions, offering a range of prescription and non-prescription pharmaceuticals. Founded in 1835 by Franz Ludwig Gehe in Dresden, Celesio AG has a long history in the industry and was formerly known as GEHE AG before rebranding in April 2003. With a focus on delivering healthcare solutions to consumers and pharmacies, Celesio AG plays a vital role in the global pharmaceutical supply chain.
PSS World Medical
Acquisition in 2013
An American distributor of medical products, equipment, billing services and pharmaceutical related products
Emendo
Acquisition in 2012
Emendo, founded in 2002 in Christchurch, New Zealand, develops healthcare patient-flow and staffing analytics software, specifically its CapPlan solution. This tool assists over 40 hospitals across New Zealand, Australia, Canada, and the UK in forecasting patient demand and optimizing resource allocation. By leveraging advanced algorithms, CapPlan enhances operational performance and patient care by effectively matching staff and physical resources. Emendo's clients have reported significant operational efficiencies and cost savings, ranging from hundreds of thousands to millions of dollars annually. Notably, the CapPlan implementation at Bedford NHS Trust received recognition in 2009 as the winner of the “Adopt, Adapt and Improve” category at the national Health and Social Care Awards in the UK.
MED3000
Acquisition in 2012
MED3000 is a healthcare management company based in Pittsburgh, Pennsylvania, established in 1995. The firm specializes in developing technology solutions and services aimed at enhancing healthcare operations. Its product offerings include billing and revenue cycle management, electronic health records, practice management, coding and compliance services, and patient outreach initiatives. MED3000 also provides solutions for EMS billing and third-party administration, along with a data warehouse for improved information management. In October 2012, the company was acquired by McKesson, strengthening its position in the healthcare technology sector.
MedVentive
Acquisition in 2012
MedVentive specializes in technology solutions that enhance the quality and cost-effectiveness of healthcare delivery. Founded by physicians in 1997, the company focuses on providing intervention and information solutions for healthcare delivery networks, payers, and employer coalitions. Its offerings include quality management, registries, pharmacy management, clinical integration, and managed care performance. Additionally, MedVentive provides point-of-care decision support and a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored intervention recommendations for patients. Through these innovative tools, MedVentive aims to facilitate meaningful improvements in healthcare outcomes and reduce overall costs.
peerVue
Acquisition in 2012
Since its inception in 2002, peerVue has been redefining the healthcare IT market with intelligent workflow and communication solutions that enable healthcare organizations to improve patient care, while also reducing risk and simplifying processes. With a passion for technology and innovation, peerVue was established to solve critical workflow and communication gaps in healthcare that jeopardize patient safety and render imaging organizations inefficient. peerVue delivers solutions worldwide with dozens of integrations to leading healthcare imaging and IT across multiple specialties, including radiology, mammography, cardiology and pathology.
Drug Trading
Acquisition in 2012
Drug Trading Company Limited operates as an independent banner business under Katz Group Canada Inc. It specializes in providing independent and franchise pharmacy banner programs and services across Canada. The company supports its pharmacy partners with a range of marketing initiatives, including flyer programs, holiday gift books for children and teenagers, and advertising campaigns at both local and national levels. By focusing on enhancing the visibility and promotional efforts of its affiliated pharmacies, Drug Trading aims to strengthen its integrated retail pharmacy network throughout the country.
Portico Systems
Acquisition in 2011
Portico Systems specializes in software applications for healthcare organizations, focusing on the management of provider networks. The company's technology facilitates the design, construction, servicing, and value-based reimbursement of complex provider networks. By automating essential network management tasks such as provider enrollment, credentialing, contracting, and pricing, Portico enhances the efficiency of health plans while reducing medical, administrative, and information technology costs. This transformation improves performance management within provider networks, ultimately supporting healthcare organizations in delivering better value to their stakeholders.
US Oncology
Acquisition in 2010
US Oncology operates as one of the largest networks of community-based oncology practices in the United States, focusing on high-quality, evidence-based cancer care. As a physician-led organization, it connects healthcare professionals who share a commitment to improving patient outcomes and quality of life through innovative practices. The network utilizes advanced healthcare information technology, evidence-based guidelines, and quality metrics to enhance cancer treatment and care delivery. It also offers a range of services, including pharmaceutical support, practice management, and cancer research, which encompass inventory management, drug mixing, billing, financial planning, and managed care contracting. By partnering with various payers, hospitals, and academic institutions, US Oncology aims to strengthen patient access to integrated care within local communities nationwide, ultimately advancing the standard of oncology services.
EN-Chart Scanning Program
Acquisition in 2008
A provider of computer-assisted facility coding and compliance solutions for emergency department visits.
McQueary Brothers
Acquisition in 2008
McQueary Bros. Drug Company, a Springfield, Missouri–based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska, and Iowa.
Vivalog Technologies
Acquisition in 2008
Vivalog Technologies specializes in developing knowledge management software tailored for hospitals and research institutions. The company offers a range of solutions, including image management for clinical trials and investigator-initiated research projects, as well as enterprise knowledge management systems designed to support decision-making and training. Additionally, Vivalog Technologies provides services for managing radiology and pathology teaching files, along with comprehensive content management solutions. Through these offerings, the company aims to enhance operational efficiency and facilitate better outcomes in the medical and research fields.
Rosebud Solutions
Acquisition in 2008
Rosebud Solutions, LLC designs, develops, markets, and supports a suite of workflow process improvement software programs.
Oncology Therapeutics Network
Acquisition in 2007
Oncology Therapeutics Network is a physician services company. It provides technology solutions, distribution services, practice management tools, and educational programs. The company offers brand and generic pharmaceuticals; Lynx Technology Platform, a charge capture and inventory management and reporting tool; Lynx EMR, a functional subscription-based electronic medical record software service; financial solutions; Web-based portal that manages various clinics' critical processes; and home delivery services for self-administered medications, as well as manages benefits investigation and insurance claims. Oncology Therapeutics Network was founded in 1990 and is headquartered in San Francisco, California.
Awarix
Acquisition in 2007
Awarix is a company based in Alabama, USA, that develops software and online tools specifically for the healthcare industry. The firm offers a digital platform designed to manage and streamline patient data effectively. Awarix's technology provides communication and reporting tools that enable operational and administrative staff in hospitals to access critical information quickly across the healthcare enterprise. This focus on improving data management and accessibility supports healthcare providers in enhancing their operational efficiency and patient care.
Practice Partner
Acquisition in 2007
Practice Partner, Inc. provides electronic health record and practice management solutions.
Per-Se Technologies
Acquisition in 2007
Per-Se Technologies is a provider of healthcare business and information technology services that aims to assist physicians and hospitals in maximizing their income potential. The company offers technology solutions designed to streamline reimbursement processes, enabling healthcare providers to receive payments more quickly. By improving financial operations, Per-Se Technologies allows healthcare businesses to concentrate more on patient care, thus enhancing overall service delivery in the healthcare sector.
RelayHealth
Acquisition in 2006
RelayHealth is a provider of online healthcare communication services that facilitates secure and convenient information exchange among various healthcare stakeholders, including patients, providers, pharmacies, payors, and pharmaceutical manufacturers. The company offers a range of services such as ePrescribing, online refills, access to lab results, reimbursable online visits, and online bill payments. By enabling consistent connectivity among medical companies, doctors, and patients, RelayHealth aims to streamline interactions within the healthcare system. This connectivity ultimately contributes to improved patient care, faster access to necessary services, reduced costs, and enhanced operational efficiency for healthcare providers.
HealthCom Partners
Acquisition in 2006
A leading provider of patient billing solutions.
Sterling Medical Services
Acquisition in 2006
Founded in 1992, Sterling Medical Services, LLC is a national provider and distributor of medical disposable supplies and health management services to the homecare market. Our customers include managed care organizations and other health insurance plans, home health nursing agencies, physician practices, rehab facilities, out-patient clinics, hospital discharge nursing, and individual patients.
NDCHealth
Acquisition in 2006
NDC Health provides healthcare information solutions. Its products and services comprise point-of-care systems, electronic prescription connections, patient scheduling, claims processing, billing, and other financial management. The company’s solutions address various administrative, clinical, and operational informational needs. It serves physicians, hospitals, pharmaceutical manufacturers, retail pharmacies, and managed care organizations.
D & K Healthcare Resources
Acquisition in 2005
D&K Healthcare Resources, Inc. operates as a wholesale drug distributor in the United States.
Medcon
Acquisition in 2005
Medcon is a global leader in cardiac image and information management solutions, focused on enhancing the quality and cost-effectiveness of healthcare. The company provides web-based products specifically designed for heart centers, including diagnostic digital image management, archiving, procedure reporting, and workflow management. These solutions facilitate rapid access to complete and accurate images and information over both local and remote networks, enabling cardiologists to deliver optimal care to patients. Medcon's software applications are developed using advanced technology and adhere to industry standards, with over 300 installations worldwide, underscoring its commitment to improving cardiac treatment and patient outcomes.
Moore Medical
Acquisition in 2004
Moore Medical is a multi-channel marketer and distributor of medical, surgical, and pharmaceutical products, serving nearly 100,000 health care practices and facilities in non-hospital settings across the nation. Its diverse customer base includes physicians, emergency medical technicians, schools, correctional institutions, municipalities, and occupational health professionals. The company has been operational for 55 years and utilizes various marketing channels, including direct mail, specialized telephone support, field sales representatives, customer community affiliates, and online platforms, to reach its clients effectively. By providing tailored solutions to specialty practice communities, Moore Medical plays a vital role in the healthcare supply chain outside of traditional hospital environments.
A.L.I. Technologies
Acquisition in 2002
A.L.I. provides medical imaging solutions which are designed to streamline access to diagnostic information, automate clinical workflow and eliminate the need for film.
MediVation
Acquisition in 2000
MediVations electronic provider-patient interface, which enables providers to transfer data to secure patient Web pages, into its clinical and administrative applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.